Literature DB >> 16424227

Redundancy in antigen-presenting function of the HLA-DR and -DQ molecules in the multiple sclerosis-associated HLA-DR2 haplotype.

Mireia Sospedra1, Paolo A Muraro, Irena Stefanová, Yingdong Zhao, Katherine Chung, Yili Li, Marc Giulianotti, Richard Simon, Roy Mariuzza, Clemencia Pinilla, Roland Martin.   

Abstract

The three HLA class II alleles of the DR2 haplotype, DRB1*1501, DRB5*0101, and DQB1*0602, are in strong linkage disequilibrium and confer most of the genetic risk to multiple sclerosis. Functional redundancy in Ag presentation by these class II molecules would allow recognition by a single TCR of identical peptides with the different restriction elements, facilitating T cell activation and providing one explanation how a disease-associated HLA haplotype could be linked to a CD4+ T cell-mediated autoimmune disease. Using combinatorial peptide libraries and B cell lines expressing single HLA-DR/DQ molecules, we show that two of five in vivo-expanded and likely disease-relevant, cross-reactive cerebrospinal fluid-infiltrating T cell clones use multiple disease-associated HLA class II molecules as restriction elements. One of these T cell clones recognizes >30 identical foreign and human peptides using all DR and DQ molecules of the multiple sclerosis-associated DR2 haplotype. A T cell signaling machinery tuned for efficient responses to weak ligands together with structural features of the TCR-HLA/peptide complex result in this promiscuous HLA class II restriction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16424227      PMCID: PMC2746197          DOI: 10.4049/jimmunol.176.3.1951

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  59 in total

1.  Molecular basis for recognition of an arthritic peptide and a foreign epitope on distinct MHC molecules by a single TCR.

Authors:  D Basu; S Horvath; I Matsumoto; D H Fremont; P M Allen
Journal:  J Immunol       Date:  2000-06-01       Impact factor: 5.422

2.  Combinatorial peptide libraries and biometric score matrices permit the quantitative analysis of specific and degenerate interactions between clonotypic TCR and MHC peptide ligands.

Authors:  Y Zhao; B Gran; C Pinilla; S Markovic-Plese; B Hemmer; A Tzou; L W Whitney; W E Biddison; R Martin; R Simon
Journal:  J Immunol       Date:  2001-08-15       Impact factor: 5.422

3.  Immunogenetic profile of multiple sclerosis in Mexicans.

Authors:  C Gorodezky; R Najera; B E Rangel; L E Castro; J Flores; G Velázquez; J Granados; J Sotelo
Journal:  Hum Immunol       Date:  1986-08       Impact factor: 2.850

Review 4.  Linkage disequilibrium in humans: models and data.

Authors:  J K Pritchard; M Przeworski
Journal:  Am J Hum Genet       Date:  2001-06-14       Impact factor: 11.025

5.  DQB1*0602 allele shows a strong association with multiple sclerosis in patients in Malaga, Spain.

Authors:  O Fernández; V Fernández; A Alonso; A Caballero; G Luque; M Bravo; A León; C Mayorga; L Leyva; E de Ramón
Journal:  J Neurol       Date:  2004-04       Impact factor: 4.849

6.  Structure of a human autoimmune TCR bound to a myelin basic protein self-peptide and a multiple sclerosis-associated MHC class II molecule.

Authors:  Yili Li; Yuping Huang; Jessica Lue; Jacqueline A Quandt; Roland Martin; Roy A Mariuzza
Journal:  EMBO J       Date:  2005-08-04       Impact factor: 11.598

7.  A functional and structural basis for TCR cross-reactivity in multiple sclerosis.

Authors:  Heather L E Lang; Helle Jacobsen; Shinji Ikemizu; Christina Andersson; Karl Harlos; Lars Madsen; Peter Hjorth; Leif Sondergaard; Arne Svejgaard; Kai Wucherpfennig; David I Stuart; John I Bell; E Yvonne Jones; Lars Fugger
Journal:  Nat Immunol       Date:  2002-09-03       Impact factor: 25.606

Review 8.  Human T-cell receptor variable gene segment families.

Authors:  B Arden; S P Clark; D Kabelitz; T W Mak
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

9.  Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR.

Authors:  D G Doherty; J E Penzotti; D M Koelle; W W Kwok; T P Lybrand; S Masewicz; G T Nepom
Journal:  J Immunol       Date:  1998-10-01       Impact factor: 5.422

10.  Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones.

Authors:  K W Wucherpfennig; A Sette; S Southwood; C Oseroff; M Matsui; J L Strominger; D A Hafler
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307

View more
  13 in total

1.  ATG-dependent phagocytosis in dendritic cells drives myelin-specific CD4+ T cell pathogenicity during CNS inflammation.

Authors:  Christian W Keller; Christina Sina; Monika B Kotur; Giulia Ramelli; Sarah Mundt; Isaak Quast; Laure-Anne Ligeon; Patrick Weber; Burkhard Becher; Christian Münz; Jan D Lünemann
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-12       Impact factor: 11.205

2.  Deconstruction of HLA-DRB1*04:01:01 and HLA-DRB1*15:01:01 class II haplotypes using next-generation sequencing in European-Americans with multiple sclerosis.

Authors:  Lisa E Creary; Kalyan C Mallempati; Sridevi Gangavarapu; Stacy J Caillier; Jorge R Oksenberg; Marcelo A Fernández-Viňa
Journal:  Mult Scler       Date:  2018-04-23       Impact factor: 6.312

3.  Complete nucleotide sequence characterization of DRB5 alleles reveals a homogeneous allele group that is distinct from other DRB genes.

Authors:  Konstantinos Barsakis; Farbod Babrzadeh; Anjo Chi; Kalyan Mallempati; William Pickle; Michael Mindrinos; Marcelo A Fernández-Viña
Journal:  Hum Immunol       Date:  2019-04-05       Impact factor: 2.850

Review 4.  Revealing the genetic basis of multiple sclerosis: are we there yet?

Authors:  Sergio E Baranzini
Journal:  Curr Opin Genet Dev       Date:  2011-01-17       Impact factor: 5.578

5.  Absence of the tag polymorphism for the risk haplotype HLA-DR2 for multiple sclerosis in Wixárika subjects from Mexico.

Authors:  G V González-Enríquez; B M Torres-Mendoza; J Márquez-Pedroza; M A Macías-Islas; G G Ortiz; J A Cruz-Ramos
Journal:  Immunogenetics       Date:  2018-02-03       Impact factor: 2.846

6.  Identification of B cell and T cell epitopes using synthetic peptide combinatorial libraries.

Authors:  Clemencia Pinilla; Jon R Appel; Valeria Judkowski; Richard A Houghten
Journal:  Curr Protoc Immunol       Date:  2012-11

7.  Uncoupling the roles of HLA-DRB1 and HLA-DRB5 genes in multiple sclerosis.

Authors:  Stacy J Caillier; Farren Briggs; Bruce A C Cree; Sergio E Baranzini; Marcelo Fernandez-Viña; Patricia P Ramsay; Omar Khan; Walter Royal; Stephen L Hauser; Lisa F Barcellos; Jorge R Oksenberg
Journal:  J Immunol       Date:  2008-10-15       Impact factor: 5.422

8.  Multiple sclerosis: Molecular mimicry of an antimyelin HLA class I restricted T-cell receptor.

Authors:  Geraldine Rühl; Anna G Niedl; Atanas Patronov; Katherina Siewert; Stefan Pinkert; Maria Kalemanov; Manuel A Friese; Kathrine E Attfield; Iris Antes; Reinhard Hohlfeld; Klaus Dornmair
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-05-17

9.  Cumulative autoimmunity: T cell clones recognizing several self-epitopes exhibit enhanced pathogenicity.

Authors:  Roland S Liblau; Hartmut Wekerle; Roland M Tisch
Journal:  Front Immunol       Date:  2011-10-05       Impact factor: 7.561

10.  Microarray analysis in B cells among siblings with/without MS - role for transcription factor TCF2.

Authors:  Jagannadha R Avasarala; Sridar V Chittur; Ajish D George; John A Tine
Journal:  BMC Med Genomics       Date:  2008-01-31       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.